These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7022973)

  • 21. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of daily followed by twice- or once-weekly regimens of ethambutol and rifampicin in the retreatment of patients with pulmonary tuberculosis: second report.
    Tubercle; 1976 Jun; 57(2):105-13. PubMed ID: 822547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
    Long MW; Snider DE; Farer LS
    Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of two twice-weekly and a once-weekly continuation regimen of tuberculosis chemotherapy, including a comparison of two durations of treatment. 2. Second report: the results at 36 months.
    Tubercle; 1977 Sep; 58(3):129-36. PubMed ID: 339448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. Tuberculosis Research Centre, Madras, and National Tuberculosis Institute, Bangalore.
    Am Rev Respir Dis; 1986 Jul; 134(1):27-33. PubMed ID: 3524334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: results up to 30 months.
    Tubercle; 1975 Sep; 56(3):179-89. PubMed ID: 766340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year assessment of controlled trials of short-course chemotherapy regimens of 6, 9 or 18 months' duration for spinal tuberculosis in patients ambulatory from the start or undergoing radical surgery. Fourteenth report of the Medical Research Council Working Party on Tuberculosis of the Spine.
    ; Darbyshire J
    Int Orthop; 1999; 23(2):73-81. PubMed ID: 10422019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose ethambutol: its role in intermittent chemotherapy. A six-year study.
    Albert RK; Sbarbaro JA; Hudson LD; Iseman M
    Am Rev Respir Dis; 1976 Oct; 114(4):699-704. PubMed ID: 970746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 5-year study of patients with pulmonary tuberculosis treated at home in a controlled comparison of isoniazid plus PAS with 3 regimens of isoniazid alone.
    Evans C; Devadatta S; Fox W; Gangadharam PR; Menon NK; Ramakrishnan CV; Sivasubramanian S; Somasundaram PR; Stott H; Velu S
    Bull World Health Organ; 1969; 41(1):1-16. PubMed ID: 5309083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two phase chemotherapy with streptomycin isoniazid and ethambutol, followed by isoniazid and ethambutol.
    Purohit SD; Sharma GS; Bomb BS
    J Assoc Physicians India; 1975 Jun; 23(6):385-9. PubMed ID: 1184566
    [No Abstract]   [Full Text] [Related]  

  • 33. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
    Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of a daily and three intermittent retreatment regimens for pulmonary tuberculosis administered under programme conditions.
    Hong YP; Kim SC; Chang SC; Kim SJ; Jin BW; Park CD
    Tubercle; 1988 Dec; 69(4):241-53. PubMed ID: 3076999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
    Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.
    Jindani A; Nunn AJ; Enarson DA
    Lancet; 2004 Oct 2-8; 364(9441):1244-51. PubMed ID: 15464185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis. The results at 1 year. A cooperative tuberculosis chemotherapy study in Poland.
    Tubercle; 1975 Mar; 56(1):1-26. PubMed ID: 1096388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. The results up to 30 months.
    Am Rev Respir Dis; 1977 May; 115(5):727-35. PubMed ID: 857713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis.
    Tubercle; 1983 Sep; 64(3):153-66. PubMed ID: 6356538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1987 Dec; 136(6):1339-42. PubMed ID: 2891333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.